Primary plasma cell leukemia
Open Access
- 28 October 2009
- Vol. 115 (24), 5734-5739
- https://doi.org/10.1002/cncr.24700
Abstract
BACKGROUND: Primary plasma cell leukemia (PCL) is a rare plasma cell disorder, and current knowledge regarding survival in this disease is limited to small series of patients. Although there has been significant improvement in the survival of patients with multiple myeloma (MM) over the past few decades, it is not known whether there has been a similar trend for PCL. METHODS: The authors analyzed the Surveillance, Epidemiology, and End Results (SEER) database to evaluate the characteristics and survival of patients who had PCL compared with those of patients who had MM. RESULTS: Among 291 patients with PCL, the median age was 67 years (range, 19-98 years), the distribution of men and women was nearly equal, and the majority of patients were white (79.4%). The median overall survival (OS) was 4 months and the median disease-specific survival (DSS) was 6 months for patients with PCL; the 1-year, 2-year, and 5-year OS rates were 27.8%, 14.1%, and 6.4%, respectively. There were no survival differences noted according to sex or race. Patients aged P = .007), although the 5-year OS was equally poor in both groups (6.3% vs 6.4%, respectively). During the same period, 49,106 patients with MM were identified. Unlike MM, in which there has been a modest but statistically significant improvement in OS and DSS noted over time, no significant improvement was evident for PCL. CONCLUSIONS: The poor long-term outcome and the lack of survival improvement in PCL suggest the need for better therapeutic options for these patients. Cancer 2009. © 2009 American Cancer Society.Keywords
This publication has 18 references indexed in Scilit:
- Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: Do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?Leukemia Research, 2008
- Improved survival in multiple myeloma and the impact of novel therapiesBlood, 2008
- Recent major improvement in long-term survival of younger patients with multiple myelomaBlood, 2008
- Genetic aberrations and survival in plasma cell leukemiaLeukemia, 2008
- Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003Journal of Clinical Oncology, 2007
- Efficacy and safety of bortezomib in patients with plasma cell leukemiaCancer, 2007
- Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia.Leukemia & Lymphoma, 2007
- Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique HématologiqueBlood, 2001
- Primary plasma cell leukaemiaBritish Journal of Haematology, 1994
- Plasma cell leukemia: An evaluation of response to therapyAmerican Journal Of Medicine, 1987